| 1 |
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
Qinghua Zhang, Chao Wang, Maoyong Zheng et al. · Cerebrovascular Diseases
ReviewOpen access |
24 Dec 2014 |
11,556 |
| 2 |
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members: et al. · European Heart Journal
Open access |
3 May 2012 |
8,531 |
| 3 |
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars C. Wallentin, Richard C. Becker, Andrzej Budaj et al. · New England Journal of Medicine
Open access |
30 Aug 2009 |
7,154 |
| 4 |
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
Stephen D. Wiviott, Eugene Braunwald, Carolyn H. McCabe et al. · New England Journal of Medicine
Open access |
4 Nov 2007 |
6,822 |
| 5 |
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigato · New England Journal of Medicine
Open access |
16 Aug 2001 |
6,519 |
| 6 |
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Scott M. Grundy et al. · Circulation
Open access |
17 Jan 2019 |
6,261 |
| 7 |
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
Lennart Hansson, Alberto Zanchetti, S. George Carruthers et al. · The Lancet
|
Jun 1998 |
5,794 |
| 8 |
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
Sam Schulman, Clive Kearon · Journal of Thrombosis and Haemostasis
Open access |
Apr 2005 |
5,063 |
| 9 |
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
Robert G. Hart, Lesly A. Pearce, Maria I. Aguilar · Annals of Internal Medicine
|
19 Jun 2007 |
4,830 |
| 10 |
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
Ron Pisters, Deirdre A. Lane, Robby Nieuwlaat et al. · CHEST Journal
Open access |
18 Mar 2010 |
4,546 |
| 11 |
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
Roxana Mehran, Sunil V. Rao, Deepak L. Bhatt et al. · Circulation
|
14 Jun 2011 |
4,530 |
| 12 |
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
Ellen Catherine Keeley, Judith Boura, Cindy Lee Grines · The Lancet
|
2003 |
4,375 |
| 13 |
Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal
G. V. R. Born · Nature
|
Jun 1962 |
4,308 |
| 14 |
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members et al. · EP Europace
Open access |
24 Aug 2012 |
3,829 |
| 15 |
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients
Sam Schulman, Ulf Angerås, David Bergqvist et al. · Journal of Thrombosis and Haemostasis
Open access |
30 Oct 2009 |
3,778 |
| 16 |
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Franklin H. Epstein, Valentı́n Fuster, Lina Badimon et al. · New England Journal of Medicine
|
30 Jan 1992 |
3,733 |
| 17 |
An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
Salvador Moncada, Ryszard Jerzy Gryglewski, S Bunting et al. · Nature
|
Oct 1976 |
3,608 |
| 18 |
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Glenn N. Levine, Eric Bates, James C. Blankenship et al. · Circulation
Open access |
8 Nov 2011 |
3,304 |
| 19 |
The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
Elliott M. Antman, Marc C. Cohen, Peter J. L. M. Bernink et al. · JAMA
|
16 Aug 2000 |
3,276 |
| 20 |
Effects of Torcetrapib in Patients at High Risk for Coronary Events
Philip J. Barter, Mark J. Caulfield, Mats A. L. Eriksson et al. · New England Journal of Medicine
Open access |
5 Nov 2007 |
3,168 |
| 21 |
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
Ιoannis Iakovou · JAMA
Open access |
3 May 2005 |
3,137 |
| 22 |
Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention
Steven R. Steinhubl, Peter B. Berger, James Tift Mann et al. · JAMA
|
20 Nov 2002 |
3,093 |
| 23 |
Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
Mats Hámberg, Jan Olof Svensson, Bengt Samuelsson · Proceedings of the National Academy of Sciences
Open access |
Aug 1975 |
3,065 |
| 24 |
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Marco Valgimigli et al. · European Heart Journal
Open access154 authors |
26 Aug 2017 |
3,025 |
| 25 |
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Inv · New England Journal of Medicine
Open access |
9 Aug 2006 |
2,914 |
| 26 |
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Lars Norgren, William R. Hiatt, John Dormandy et al. · European Journal of Vascular and Endovascular Surgery
Open access |
30 Nov 2006 |
2,868 |
| 27 |
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Deepak L. Bhatt et al. · New England Journal of Medicine
Open access |
12 Mar 2006 |
2,837 |
| 28 |
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
Shamir R. Mehta, Salim Yusuf, Ron J.G. Peters et al. · The Lancet
|
Aug 2001 |
2,820 |
| 29 |
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
The EPIC Investigators · New England Journal of Medicine
Open access |
7 Apr 1994 |
2,610 |
| 30 |
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
Jessica L. Mega, Sandra L. Close, Stephen D. Wiviott et al. · New England Journal of Medicine
Open access |
22 Dec 2008 |
2,503 |
| 31 |
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
John W. Eikelboom et al. · New England Journal of Medicine
Open access |
27 Aug 2017 |
2,456 |
| 32 |
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
Hans‐Christoph Diener, Julien Bogousslavsky, Lawrence M. Brass et al. · The Lancet
Open access |
Jul 2004 |
2,303 |
| 33 |
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article
Sidney C. Smith et al. · Circulation
|
3 Jan 2006 |
2,226 |
| 34 |
Stroke
Geoffrey Alan Donnan, Marc Fisher, Malcolm Robert Macleod et al. · The Lancet
|
May 2008 |
2,224 |
| 35 |
Platelet Activation and Atherothrombosis
Giovanni Davı̀, Carlo Patrono · New England Journal of Medicine
|
12 Dec 2007 |
2,157 |
| 36 |
Prevention of VTE in Nonorthopedic Surgical Patients
Michael K. Gould, David García, Sherry M. Wren et al. · CHEST Journal
Open access |
Feb 2012 |
2,137 |
| 37 |
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
The ACTIVE Investigators · New England Journal of Medicine
Open access |
31 Mar 2009 |
2,107 |
| 38 |
A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
Frits R. Rosendaal, Suzanne C. Cannegieter, Felix J.M. van der Meer et al. · Thrombosis and Haemostasis
Open access |
1993 |
2,077 |
| 39 |
A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery Stents
Albert Schömig, Franz–Josef Neumann, Adnan Kastrati et al. · New England Journal of Medicine
|
25 Apr 1996 |
2,039 |
| 40 |
A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction
Cindy Lee Grines, Kevin F. Browne, Jean Marco et al. · New England Journal of Medicine
Open access |
11 Mar 1993 |
2,004 |
| 41 |
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca et al. · New England Journal of Medicine
Open access |
14 Mar 2015 |
2,003 |
| 42 |
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
Paul M. Ridker, Nancy R. Cook, I‐Min Lee et al. · New England Journal of Medicine
|
7 Mar 2005 |
1,962 |
| 43 |
Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation
Marc Steven Sabatine, Christopher Paul Cannon, Charles Michael Gibson et al. · New England Journal of Medicine
|
10 Mar 2005 |
1,935 |
| 44 |
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Laura Mauri et al. · New England Journal of Medicine
Open access |
16 Nov 2014 |
1,928 |
| 45 |
Mechanisms of Thrombus Formation
Bruce Furie, Barbara C. Furie · New England Journal of Medicine
|
27 Aug 2008 |
1,925 |
| 46 |
Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
The EPILOG Investigators · New England Journal of Medicine
Open access |
12 Jun 1997 |
1,900 |
| 47 |
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
Yongjun Wang, Yilong Wang, Xingquan Zhao et al. · New England Journal of Medicine
Open access |
26 Jun 2013 |
1,877 |
| 48 |
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy E. Neunert, Wendy Lim, Mark Andrew Crowther et al. · Blood
|
16 Feb 2011 |
1,869 |
| 49 |
A Platelet-Dependent Serum Factor That Stimulates the Proliferation of Arterial Smooth Muscle Cells In Vitro
Russell Ross, John Glomset, Beverly Kariya et al. · Proceedings of the National Academy of Sciences
Open access |
Apr 1974 |
1,858 |
| 50 |
A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting
Martin B. Leon, Donald S. Baim, Jeffrey J. Popma et al. · New England Journal of Medicine
Open access |
3 Dec 1998 |
1,826 |